Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$334.23 - $403.65 $668 - $807
-2 Reduced 20.0%
8 $2,000
Q4 2022

Jan 31, 2023

BUY
$342.17 - $402.31 $2,395 - $2,816
7 Added 233.33%
10 $3,000
Q3 2022

Oct 21, 2022

SELL
$343.2 - $395.75 $1,029 - $1,187
-3 Reduced 50.0%
3 $1,000
Q2 2022

Aug 01, 2022

BUY
$269.58 - $378.88 $1,617 - $2,273
6 New
6 $2,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Schubert & CO Portfolio

Follow Schubert & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

News

Stay updated on Schubert & CO with notifications on news.